Response To: ‘Could Abatacept Directly Target Expanded Plasmablasts in IgG4-related Disease?’ by Alegriaet Al

Annals of the Rheumatic Diseases - United Kingdom
doi 10.1136/annrheumdis-2016-210403
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Could Abatacept Directly Target Expanded Plasmablasts in IgG4-related Disease?

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2016English

IgG4 Levels and Plasmablasts as a Marker for IgG4-related Disease (IgG4-RD)

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2014English

De Novo Oligoclonal Expansions of Circulating Plasmablasts in Active and Relapsing IgG4-related Disease

English

IgG4-related Thyroid Disease

2020English

IgG4 Related Cardiac Disease

Methodist DeBakey cardiovascular journal
Medicine
2013English

IgG4-Related Sclerosing Disease

2011English

IgG4-related Disease in Endocrine Practice

Archives of Medical Science
Medicine
2019English

Selective Response to Rituximab in a Patient With Salivary Gland-Predominant IgG4-Related Disease.

Journal of Allergy and Clinical Immunology
AllergyImmunology
2017English

Outline of IgG4-related Disease

The Japanese Journal of Sarcoidosis and Other Granulomatous Disorders
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy